Improving Global Patient Care: CAP Partners with the IARC-WHO to Streamline Updates to Cancer Protocols

TAGGED : cancer

MAIA Biotechnology Reveals Higher Anticancer Potency of Telomere-Targeting Compounds Derived from THIO

October 30, 2023

CHICAGO--(BUSINESS WIRE)--Oct 30, 2023--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced positive results from an investigational new drug-enabling study of the Company蘑菇视频 second-generation ...

Sonata Therapeutics Announces Presentations Supporting its Network Medicines鈩� Approach at SITC 2023

October 30, 2023

WATERTOWN, Mass.--(BUSINESS WIRE)--Oct 30, 2023--<a ...

European Medicines Agency Validates Bristol Myers Squibb蘑菇视频 Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

October 30, 2023

PRINCETON, N.J.--(BUSINESS WIRE)--Oct 30, 2023--<a ...

Merck KGaA, Darmstadt, Germany, Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

October 30, 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Oct 30, 2023--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldwide (ex-China) to ...

Veracyte Announces SITC 2023 Presentations Offering New Insight into Immuno-oncology Drug Development

October 27, 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 27, 2023--<a ...

ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

October 27, 2023

WALTHAM, Mass.--(BUSINESS WIRE)--Oct 27, 2023--<a ...